CAC 40
8 049,78 -42,08 (-0,52 %) Euro Stoxx 50
4 967,37 -22,51 (-0,45 %) Dow Jones
38 460,92 -42,77 (-0,11 %) EUR/USD
1,0727 +0,0026 (+0,25 %) Gold future
2 337,60 -0,80 (-0,03 %) Bitcoin EUR
59 731,67 -2 138,06 (-3,46 %)
Fresenius Medical Care AG (FMCQF)
Fresenius Medical Care AG
Else-KrOener-Strasse 1
Bad Homburg 61352
Germany
49 6172 609 0
https://www.freseniusmedicalcare.com
Secteur(s): Healthcare
Secteur d’activité: Medical Care Facilities
Employés à temps plein: 119 845
Dirigeants clés
| Nom | Titre | Payer | Exercé | Année de naissance |
|---|---|---|---|---|
| Ms. Helen Giza | CEO & Chair of Management Board of Fresenius Med. Care Mgmt AG | 5,28M | S.O. | 1968 |
| Mr. Martin Fischer | CFO & Member of the Management Board of Fresenius Medical Care Management AG | 949,34k | S.O. | 1977 |
| Dr. Franklin W. Maddux F.A.C.P. | Global Chief Medical Officer & Member of Management Board of Fresenius Medical Care Management AG | 2,97M | S.O. | 1957 |
| Dr. Katarzyna Mazur-Hofsab Ph.D. | Management Board Member for Care Enablement of Fresenius Medical Care Management AG | 3,09M | S.O. | 1963 |
| Mr. Craig Cordola FACHE, M.B.A., M.H.A. | CEO of Care Delivery & Member of Management Board | S.O. | S.O. | 1970 |
| Dr. Dominik Heger | Executive VP and Head of Investor Relations, Strategic Development & Communications | S.O. | S.O. | S.O. |
| Mr. Joachim Weith | Senior Vice President of Corporate Communications & Governmental Affairs | S.O. | S.O. | S.O. |
| Dr. Gail-Suzanne Brown | Senior Vice President of Research & Development | S.O. | S.O. | S.O. |
| Mr. Glenn Slater | Senior Vice President of Manufacturing and Supply Chain Operations | S.O. | S.O. | S.O. |
| Dr. Wolfgang Kummerle | Senior Vice President - Quality Management International | S.O. | S.O. | S.O. |
Description
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
Gouvernance d’entreprise
L’ISS Governance QualityScore de Fresenius Medical Care AG en date du 1 avril 2024 est 8. Les scores principaux sont Audit : 3; Société : 7; Droits des actionnaires : 1; Compensation : 9.
